Detalhe da pesquisa
1.
Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 14(3): 413-20, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499929
2.
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease.
Clin Gastroenterol Hepatol
; 12(3): 423-31.e1, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24184736
3.
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol.
Gut
; 62(2): 201-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22525883
4.
Unraveling the Oral-Gut axis: Interconnection between Periodontitis and IBD, Current Challenges, and Future Perspective.
J Crohns Colitis
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417137
5.
Unraveling the Link between Periodontitis and Inflammatory Bowel Disease: Challenges and Outlook.
ArXiv
; 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645044
6.
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Am J Gastroenterol
; 106(2): 199-212; quiz 213, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21045814
7.
Vitamin C Deficiency in Inflammatory Bowel Disease: The Forgotten Micronutrient.
Crohns Colitis 360
; 3(1): otab009, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34222863
8.
A Pilot Clinical Study on Post-Operative Recurrence Provides Biological Clues for a Role of Candida Yeasts and Fluconazole in Crohn's Disease.
J Fungi (Basel)
; 7(5)2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922391
9.
Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study.
Clin Gastroenterol Hepatol
; 8(8): 696-702.e1, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20363366
10.
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab.
Clin Gastroenterol Hepatol
; 8(8): 688-695.e2, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20451663
11.
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.
Am J Gastroenterol
; 105(7): 1574-82, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20234346
12.
Candida albicans colonization and ASCA in familial Crohn's disease.
Am J Gastroenterol
; 104(7): 1745-53, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19471251
13.
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.
Clin Gastroenterol Hepatol
; 6(6): 644-53, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18550004